Tennant Co (TNC) stock
TNCNYSERefrigeration & Service Industry MachineryFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30123% above fair value
$75.03−1.22 (-1.60%)
Close on Nov 12, 2026Market cap $1.28BP/E 74.3Yield 1.59%
Earnings
Tennant's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 23, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$322.30M
+6.3% on a year earlier
Adjusted diluted EPS (a), Q3 FY2026
$1.40
$1.46 a year earlier
Latest guidance
Raised
Nov 2, 2026 · 8 items
Quarterly results
Revenue and earnings per share from each of Tennant's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 23, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 2, 2026after the close | $322.30M | +6.3% | $1.12 | $1.40 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 6, 2026during market hours | $324.00M | +1.7% | – | $0.83 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 4, 2026during market hours | $297.90M | +2.7% | $0.01 | $0.58 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 24, 2026during market hours | $291.60M | -11.3% | -$0.23 | $0.48 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 3, 2025during market hours | $303.30M | -4.0% | – | $1.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 6, 2025during market hours | $318.60M | -3.7% | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025during market hours | $290.00M | -6.8% | $0.69 | $1.12 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 18, 2025before the open | $328.90M | +5.6% | $0.35 | $1.52 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024during market hours | $315.80M | +3.6% | $1.09 | $1.39 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 8, 2024before the open | $331.00M | +2.9% | $1.45 | $1.83 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 3, 2024before the open | $311.00M | +1.7% | $1.49 | $1.81 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 22, 2024before the open | $311.40M | +7.0% | $1.64 | $1.92 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 31, 2023before the open | $304.70M | +15.9% | $1.21 | $1.34 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 4, 2023before the open | $321.70M | +14.8% | $1.68 | $1.86 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 28, 2023before the open | $305.80M | +18.5% | $1.30 | $1.45 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 23, 2023before the open | $291.00M | +5.3% | $1.27 | $1.46 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 27, 2022before the open | $262.90M | -3.3% | $0.83 | $0.99 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 9, 2022before the open | $280.20M | – | $0.89 | $0.92 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022before the open | $258.10M | – | $0.55 | $0.73 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 24, 2022before the open | $276.40M | – | $0.42 | $0.71 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 2, 2021before the open | $272.00M | – | $1.14 | $1.33 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 3, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 4, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Feb 25, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 29, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Tennant's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net salesGAAP | FY2026 | $1.27B – $1.31B | – | New | Nov 2, 2026 |
| Net sales | FY2026 | $1.24B – $1.28B | $1.24B – $1.28B | Reaffirmed | May 4, 2026 |
| Organic net sales growthnon-GAAP | FY2026 | +3.5% – +7% | – | New | Nov 2, 2026 |
| Organic net sales growthnon-GAAP | FY2026 | +3% – +6.5% | – | New | Feb 24, 2026 |
| Organic net sales growth | FY2026 | +3% – +6.5% | – | New | May 4, 2026 |
| Adjusted EBITDA**non-GAAP | FY2026 | $155.00M – $170.00M | – | New | Nov 2, 2026 |
| Adjusted EBITDA**non-GAAP | FY2026 | $175.00M – $190.00M | $175.00M – $190.00M | Reaffirmed | May 4, 2026 |
| Diluted net income per shareGAAP | FY2026 | $2.15 – $2.80 | – | New | Nov 2, 2026 |
| Diluted net income per shareGAAP | FY2026 | $4.05 – $4.65 | $4.05 – $4.65 | Reaffirmed | May 4, 2026 |
| Adjusted diluted net income per share**non-GAAP | FY2026 | $3.80 – $4.45 | – | New | Nov 2, 2026 |
| Adjusted diluted net income per share**non-GAAP | FY2026 | $4.70 – $5.30 | $4.70 – $5.30 | Reaffirmed | May 4, 2026 |
| Capital expendituresGAAP | FY2026 | $25.00M | – | New | Nov 2, 2026 |
| Capital expenditures | FY2026 | $25.00M | $25.00M | Reaffirmed | May 4, 2026 |
| Adjusted EBITDA margin**non-GAAP | FY2026 | 12.2% – 13% | – | New | Nov 2, 2026 |
| Adjusted EBITDA margin**non-GAAP | FY2026 | 14.1% – 14.8% | 14.1% – 14.8% | Lowered | May 4, 2026 |
| Adjusted effective tax rate**non-GAAP | FY2026 | 24% – 29% | – | Raised | Nov 2, 2026 |
| Adjusted effective tax rate**non-GAAP | FY2026 | 24% – 29% | 24% – 29% | Raised | May 4, 2026 |
Guidance history
Every forecast Tennant put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 2, 2026 | Capital expenditures | FY2026 | $25.00M | New |
| Nov 2, 2026 | Adjusted EBITDA** | FY2026 | $155.00M – $170.00M | New |
| Nov 2, 2026 | Adjusted diluted net income per share** | FY2026 | $3.80 – $4.45 | New |
| Nov 2, 2026 | Diluted net income per share | FY2026 | $2.15 – $2.80 | New |
| Nov 2, 2026 | Adjusted EBITDA margin** | FY2026 | 12.2% – 13% | New |
| Nov 2, 2026 | Adjusted effective tax rate** | FY2026 | 24% – 29% | Raised |
| Nov 2, 2026 | Organic net sales growth | FY2026 | +3.5% – +7% | New |
| Nov 2, 2026 | Net sales | FY2026 | $1.27B – $1.31B | New |
| May 4, 2026 | Capital expenditures | FY2026 | $25.00M | Reaffirmed |
| May 4, 2026 | Organic net sales growth | FY2026 | +3% – +6.5% | New |
| May 4, 2026 | Adjusted EBITDA** | FY2026 | $175.00M – $190.00M | Reaffirmed |
| May 4, 2026 | Adjusted diluted net income per share** | FY2026 | $4.70 – $5.30 | Reaffirmed |
| May 4, 2026 | Diluted net income per share | FY2026 | $4.05 – $4.65 | Reaffirmed |
| May 4, 2026 | Adjusted EBITDA margin** | FY2026 | 14.1% – 14.8% | Lowered |
| May 4, 2026 | Adjusted effective tax rate** | FY2026 | 24% – 29% | Raised |
| May 4, 2026 | Net sales | FY2026 | $1.24B – $1.28B | Reaffirmed |
| Feb 24, 2026 | Capital expenditures | FY2026 | $25.00M | New |
| Feb 24, 2026 | Adjusted EBITDA* | FY2026 | $175.00M – $190.00M | New |
| Feb 24, 2026 | Adjusted diluted net income per share* | FY2026 | $4.70 – $5.30 | New |
| Feb 24, 2026 | Diluted net income per share | FY2026 | $4.05 – $4.65 | New |
| Feb 24, 2026 | Adjusted effective tax rate* | FY2026 | 24% – 29% | Raised |
| Feb 24, 2026 | Adjusted EBITDA margin* | FY2026 | 14.1% – 14.8% | New |
| Feb 24, 2026 | Organic net sales growth | FY2026 | +3% – +6.5% | New |
| Feb 24, 2026 | Net sales | FY2026 | $1.24B – $1.28B | New |
| Apr 30, 2025 | Capital expenditures | FY2025 | $20.00M | Reaffirmed |
| Apr 30, 2025 | Adjusted EBITDA | FY2025 | $196.00M – $209.00M | Reaffirmed |
| Apr 30, 2025 | Adjusted diluted net income per share | FY2025 | $5.70 – $6.20 | Reaffirmed |
| Apr 30, 2025 | Diluted net income per share | FY2025 | $3.80 – $4.30 | Reaffirmed |
| Apr 30, 2025 | Adjusted EBITDA margin | FY2025 | 16.2% – 16.7% | Lowered |
| Apr 30, 2025 | Adjusted effective tax rate | FY2025 | 23% – 27% | Raised |
| Apr 30, 2025 | Organic net sales decline | FY2025 | -4% – -1% | New |
| Apr 30, 2025 | Net sales | FY2025 | $1.21B – $1.25B | Reaffirmed |
| Feb 18, 2025 | Capital expenditures | FY2025 | $20.00M | New |
| Feb 18, 2025 | Adjusted EBITDA | FY2025 | $196.00M – $209.00M | New |
| Feb 18, 2025 | Adjusted diluted net income per share | FY2025 | $5.70 – $6.20 | New |
| Feb 18, 2025 | Diluted net income per share | FY2025 | $3.80 – $4.30 | New |
| Feb 18, 2025 | Adjusted EBITDA margin | FY2025 | 16.2% – 16.7% | New |
| Feb 18, 2025 | Adjusted effective tax rate | FY2025 | 23% – 27% | Raised |
| Feb 18, 2025 | Organic net sales decline | FY2025 | -4% – -1% | New |
| Feb 18, 2025 | Net sales | FY2025 | $1.21B – $1.25B | New |
| Oct 31, 2024 | Capital expenditures | FY2024 | $20.00M | New |
| Oct 31, 2024 | Adjusted EBITDA* | FY2024 | $205.00M – $215.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted diluted net income per share* | FY2024 | $6.15 – $6.55 | Reaffirmed |
| Oct 31, 2024 | Adjusted EBITDA margin | FY2024 | 16% – 16.5% | Lowered |
| Oct 31, 2024 | Adjusted effective tax rate* | FY2024 | 22% – 27% | Raised |
| Oct 31, 2024 | Organic net sales growth | FY2024 | +2.5% – +4.5% | New |
| Oct 31, 2024 | Net sales | FY2024 | $1.28B – $1.31B | New |
| Aug 8, 2024 | Capital expenditures | FY2024 | $20.00M | Lowered |
| Aug 8, 2024 | Adjusted EBITDA | FY2024 | $205.00M – $215.00M | Raised |
| Aug 8, 2024 | Adjusted diluted net income per share | FY2024 | $6.15 – $6.55 | Narrowed |
| Aug 8, 2024 | Adjusted EBITDA margin | FY2024 | 16% – 16.5% | Lowered |
| Aug 8, 2024 | Adjusted effective tax rate | FY2024 | 22% – 27% | Raised |
| Aug 8, 2024 | Organic net sales growth | FY2024 | +2.5% – +4.5% | Raised |
| Aug 8, 2024 | Net sales | FY2024 | $1.28B – $1.31B | Raised |
| May 3, 2024 | Capital expenditures | FY2024 | $20.00M – $25.00M | New |
| May 3, 2024 | Adjusted EBITDA | FY2024 | $198.00M – $213.00M | Reaffirmed |
| May 3, 2024 | Adjusted diluted net income per share | FY2024 | $6.05 – $6.65 | Reaffirmed |
| May 3, 2024 | Adjusted EBITDA margin | FY2024 | 15.6% – 16.4% | Lowered |
| May 3, 2024 | Adjusted effective tax rate | FY2024 | 22% – 27% | Raised |
| May 3, 2024 | Organic net sales growth | FY2024 | +2% – +4% | New |
| May 3, 2024 | Net sales | FY2024 | $1.27B – $1.30B | Reaffirmed |
| Feb 22, 2024 | Capital expenditures | FY2024 | $20.00M – $25.00M | New |
| Feb 22, 2024 | Adjusted EBITDA | FY2024 | $198.00M – $213.00M | New |
| Feb 22, 2024 | Adjusted diluted net income per share | FY2024 | $6.05 – $6.65 | New |
| Feb 22, 2024 | Adjusted EBITDA margin | FY2024 | 15.6% – 16.4% | New |
| Feb 22, 2024 | Adjusted effective tax rate | FY2024 | 22% – 27% | Raised |
| Feb 22, 2024 | Organic net sales growth | FY2024 | +2% – +4% | New |
| Feb 22, 2024 | Net sales | FY2024 | $1.27B – $1.30B | New |
| Oct 31, 2023 | Capital expenditures | FY2023 | $20.00M – $25.00M | Reaffirmed |
| Oct 31, 2023 | Adjusted EBITDA* | FY2023 | $190.00M – $200.00M | Raised |
| Oct 31, 2023 | Adjusted diluted net income per share* | FY2023 | $5.70 – $6.10 | Raised |
| Oct 31, 2023 | Diluted net income per share | FY2023 | $5.00 – $5.40 | Raised |
| Oct 31, 2023 | Adjusted EBITDA margin | FY2023 | 15.4% – 16% | Lowered |
| Oct 31, 2023 | Adjusted effective tax rate* | FY2023 | 20% – 25% | Raised |
| Oct 31, 2023 | Organic net sales growth | FY2023 | +12.5% – +14.5% | Raised |
| Oct 31, 2023 | Net sales | FY2023 | $1.23B – $1.25B | Raised |
| Aug 4, 2023 | Capital expenditures | FY2023 | $20.00M – $25.00M | Reaffirmed |
| Aug 4, 2023 | Adjusted EBITDA* | FY2023 | $175.00M – $190.00M | Raised |
| Aug 4, 2023 | Adjusted diluted net income per share* | FY2023 | $5.10 – $5.75 | Raised |
| Aug 4, 2023 | Diluted net income per share | FY2023 | $4.30 – $4.95 | New |
| Aug 4, 2023 | Adjusted EBITDA margin | FY2023 | 14.6% – 15.2% | Lowered |
| Aug 4, 2023 | Adjusted effective tax rate* | FY2023 | 20% – 25% | Raised |
| Aug 4, 2023 | Organic net sales growth | FY2023 | +10% – +14% | Raised |
| Aug 4, 2023 | Net sales | FY2023 | $1.20B – $1.25B | Raised |
| Apr 28, 2023 | Capital expenditures | FY2023 | $20.00M – $25.00M | Reaffirmed |
| Apr 28, 2023 | Adjusted EBITDA* | FY2023 | $140.00M – $160.00M | Reaffirmed |
| Apr 28, 2023 | Adjusted diluted net income per share* | FY2023 | $3.70 – $4.50 | Reaffirmed |
| Apr 28, 2023 | Adjusted effective tax rate** | FY2023 | 20% – 25% | Reaffirmed |
| Apr 28, 2023 | Organic net sales growth | FY2023 | +3% – +7% | Reaffirmed |
| Apr 28, 2023 | Net sales | FY2023 | $1.12B – $1.16B | Reaffirmed |
| Feb 23, 2023 | Capital expenditures | FY2023 | $20.00M – $25.00M | New |
| Feb 23, 2023 | Adjusted EBITDA | FY2023 | $140.00M – $160.00M | New |
| Feb 23, 2023 | Adjusted diluted net income per share | FY2023 | $3.70 – $4.50 | New |
| Feb 23, 2023 | Adjusted effective tax rate | FY2023 | 20% – 25% | New |
| Feb 23, 2023 | Organic net sales growth | FY2023 | +3% – +7% | New |
| Feb 23, 2023 | Net sales | FY2023 | $1.12B – $1.16B | New |
| Oct 27, 2022 | Capital expenditures | FY2022 | $25.00M – $30.00M | New |
| Oct 27, 2022 | Adjusted EBITDA | FY2022 | $130.00M – $140.00M | Lowered |
| Oct 27, 2022 | Adjusted diluted net income per share | FY2022 | $3.70 – $4.10 | Lowered |
| Oct 27, 2022 | Diluted net income per share | FY2022 | $3.20 – $3.60 | Lowered |
| Oct 27, 2022 | Adjusted effective tax rate | FY2022 | 20% – 25% | Reaffirmed |
| Oct 27, 2022 | Organic net sales growth | FY2022 | +3% – +6% | Lowered |
| Oct 27, 2022 | Net sales | FY2022 | $1.08B – $1.11B | Lowered |
| Aug 9, 2022 | Capital expenditures | FY2022 | $25.00M – $30.00M | Reaffirmed |
| Aug 9, 2022 | Adjusted EBITDA | FY2022 | $140.00M – $155.00M | Reaffirmed |
| Aug 9, 2022 | Adjusted diluted net income per share* | FY2022 | $4.15 – $4.75 | Reaffirmed |
| Aug 9, 2022 | Diluted net income per share | FY2022 | $3.65 – $4.25 | Reaffirmed |
| Aug 9, 2022 | Adjusted effective tax rate** | FY2022 | 20% – 25% | Reaffirmed |
| Aug 9, 2022 | Organic net sales growth | FY2022 | +6% – +10% | Raised |
| Aug 9, 2022 | Net sales | FY2022 | $1.13B – $1.17B | Reaffirmed |
| Apr 28, 2022 | Capital expenditures | FY2022 | $25.00M – $30.00M | Reaffirmed |
| Apr 28, 2022 | Adjusted EBITDA | FY2022 | $140.00M – $155.00M | Lowered |
| Apr 28, 2022 | Adjusted diluted net income per share* | FY2022 | $4.15 – $4.75 | Lowered |
| Apr 28, 2022 | Diluted net income per share | FY2022 | $3.65 – $4.25 | Lowered |
| Apr 28, 2022 | Adjusted effective tax rate* | FY2022 | 20% – 25% | Reaffirmed |
| Apr 28, 2022 | Organic net sales growth | FY2022 | +4.5% – +8.5% | New |
| Apr 28, 2022 | Net sales | FY2022 | $1.13B – $1.17B | Reaffirmed |
| Feb 24, 2022 | Capital expenditures | FY2022 | $25.00M – $30.00M | New |
| Feb 24, 2022 | Adjusted EBITDA | FY2022 | $145.00M – $160.00M | New |
| Feb 24, 2022 | Adjusted diluted net income per share* | FY2022 | $4.40 – $5.00 | New |
| Feb 24, 2022 | Diluted net income per share | FY2022 | $3.90 – $4.50 | New |
| Feb 24, 2022 | Adjusted effective tax rate* | FY2022 | 20% – 25% | New |
| Feb 24, 2022 | Organic net sales growth | FY2022 | +4.5% – +8.5% | New |
| Feb 24, 2022 | Net sales | FY2022 | $1.13B – $1.17B | New |
| Nov 2, 2021 | Capital expenditures | FY2021 | $20.00M | New |
| Nov 2, 2021 | Adjusted EBITDA | FY2021 | $137.00M – $142.00M | New |
| Nov 2, 2021 | Adjusted EPS | FY2021 | $4.20 – $4.40 | New |
| Nov 2, 2021 | reported GAAP earnings | FY2021 | $3.50 – $3.70 | New |
| Nov 2, 2021 | adjusted effective tax rate | FY2021 | 15% | New |
| Nov 2, 2021 | organic sales growth | FY2021 | +9% – +10% | New |
| Nov 2, 2021 | Net sales | FY2021 | $1.09B – $1.10B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Tennant filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
See a number that looks wrong?